News

Very positive article on EDAP’s future and its advances on #HIFU, written by Seeking Alpha. Summary - Favorable changes in market acceptance and reimbursement for the FocalOne have been obscured by pandemic headwinds. - However, the company continues at breakeven because of strong growth in its distribution business, the result of a fantastic strategic deal with Exact Imaging. - While pandemic headwinds could blow a little longer, sooner or later the lid will be blown off of FocalOne installation growth and as long as the distribution business. - As long as the distribution business keeps on delivering, the wait isn't problematic and the shares are already attractive at $6 and change.